| Nota de fuente |
Subcutaneous rituximab for the treatment of B-Cell hematologic malignancies, 2017---port. (Andrew Davies, Claude Berge, Axel Boehnke, Anjum Dadabhoy, Pieternella Lugtenburg, Simon Rule, Mathias Rummel, Christine McIntyre, Rodney Smith and Xavier Badoux)
|
